glp 1 for intracranial hypertension The effect of GLP-1 agonist on idiopathic hypertension: a systematic review and meta-analysis Large-Scale Study Highlights Therapeutic Benefits

Diabetes, Obesity & Metabolism, 24(1), 94105

Diarrhea or constipation : The medication can affect the regularity of your bowel movements

Diagnostic methods, including transient elastography and non-invasive fibrosis indicators, modify the liver monitoring

Heres what you need to know: GLP-1 and GIP are both incretin hormones your gut releases after eating

Many patients find that continuous, low-cost access makes indefinite treatment feasiblepreventing the weight-regain cycle entirely

Review article: Role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know